Skip to main content
. 2024 Sep 25;38(12):2554–2560. doi: 10.1038/s41375-024-02404-6

Fig. 3. Survival outcomes with RWCP therapies.

Fig. 3

Kaplan–Meier plots showing (A) progression-free survival and B overall survival based on RRC assessment at median study follow-up 26.4 months in all patients. OS overall survival, PFS progression-free survival, RRC response review committee, VGPR very good partial response.